Public Act 096-1078 Public Act 1078 96TH GENERAL ASSEMBLY |
Public Act 096-1078 | SB2931 Enrolled | LRB096 17757 KTG 35199 b |
|
| AN ACT concerning public aid.
| Be it enacted by the People of the State of Illinois,
| represented in the General Assembly:
| Section 1. Short title. This Act may be cited as the | Pediatric Palliative Care Act. | Section 5. Legislative findings. The General Assembly | finds as follows: | (1) Each year, approximately 1,185 Illinois children | are diagnosed with a potentially life-limiting illness. | (2) There are many barriers to the provision of | pediatric palliative services, the most significant of | which include the following: (i) challenges in predicting | life expectancy; (ii) the reluctance of families and | professionals to acknowledge a child's incurable | condition; and (iii) the lack of an appropriate, | pediatric-focused reimbursement structure leading to | insufficient community-based resources. | (3) It is tremendously difficult for physicians to | prognosticate pediatric life expectancy due to the | resiliency of children. In addition, parents are rarely | prepared to cease curative efforts in order to receive | hospice or palliative care. Community-based pediatric | palliative services, however, keep children out of the |
| hospital by managing many symptoms in the home setting, | thereby improving childhood quality of life while | maintaining budget neutrality.
| (4) Pediatric palliative programming can, and should, | be administered in a cost neutral fashion. Community-based | pediatric palliative care allows for children and families | to receive pain and symptom management and psychosocial | support in the comfort of the home setting, thereby | avoiding excess spending for emergency room visits and | certain hospitals. The National Hospice and Palliative | Care Organization's pediatric task force reported during | 2001 that the average cost per child per year, cared for | primarily at home, receiving comprehensive palliative and | life prolonging services concurrently, is $16,177, | significantly less than the $19,000 to $48,000 per child | per year when palliative programs are not utilized. | Section 10. Definition. In this Act, "Department" means the | Department of Healthcare and Family Services. | Section 15. Pediatric palliative care pilot program. The | Department shall develop a pediatric palliative care pilot | program under which a qualifying child as defined in Section 25 | may receive community-based pediatric palliative care from a | trained interdisciplinary team while continuing to pursue | aggressive curative treatments for a potentially life-limiting |
| illness under the benefits available under Article V of the | Illinois Public Aid Code. | Section 20. Federal waiver or State Plan amendment. The | Department shall submit the necessary application to the | federal Centers for Medicare and Medicaid Services for a waiver | or State Plan amendment to implement the pilot program | described in this Act. If the application is in the form of a | State Plan amendment, the State Plan amendment shall be filed | prior to December 31, 2010. If the Department does not submit a | State Plan amendment prior to December 31, 2010, the pilot | program shall be created utilizing a waiver authority. The | waiver request shall be included in any appropriate waiver | application renewal submitted prior to December 31, 2011, or | shall be submitted as an independent 1915(c) Home and Community | Based Medicaid Waiver within that same time period. After | federal approval is secured, the Department shall implement the | waiver or State Plan amendment within 12 months of the date of | approval. By federal requirement, the application for a 1915 | (c) Medicaid waiver program must demonstrate cost neutrality | per the formula laid out by the Centers for Medicare and | Medicaid Services. The Department shall not draft any rules in | contravention of this timetable for pilot program development | and implementation. This pilot program shall be implemented | only to the extent that federal financial participation is | available. |
| Section 25. Qualifying child. | (a) For the purposes of this Act, a qualifying child is a | person under 18 years of age who is enrolled in the medical | assistance program under Article V of the Illinois Public Aid | Code and suffers from a potentially life-limiting medical | condition, as defined in subsection (b). A child who is | enrolled in the pilot program prior to the age 18 may continue | to receive services under the pilot program until the day | before his or her twenty-first birthday.
| (b) The Department, in consultation with interested | stakeholders, shall determine the potentially life-limiting | medical conditions that render a pediatric medical assistance | recipient eligible for the pilot program under this Act. Such | medical conditions shall include, but need not be limited to, | the following: | (1) Cancer (i) for which there is no known effective | treatment, (ii) that does not respond to conventional | protocol, (iii) that has progressed to an advanced stage, | or (iv) where toxicities or other complications prohibit | the administration of curative therapies. | (2) End-stage lung disease, including but not limited | to cystic fibrosis, that results in dependence on | technology, such as mechanical ventilation. | (3) Severe neurological conditions, including, but not | limited to, hypoxic ischemic encephalopathy, acute brain |
| injury, brain infections and inflammatory diseases, or | irreversible severe alteration of mental status, with one | of the following co-morbidities: (i) intractable seizures | or (ii) brainstem failure to control breathing or other | automatic physiologic functions. | (4) Degenerative neuromuscular conditions, including, | but not limited to, spinal muscular atrophy, Type I or II, | or Duchenne Muscular Dystrophy, requiring technological | support. | (5) Genetic syndromes, such as Trisomy 13 or 18, where | (i) it is more likely than not that the child will not live | past 2 years of age or (ii) the child is severely | compromised with no expectation of long-term survival. | (6) Congenital or acquired end-stage heart disease, | including but not limited to the following: (i) single | ventricle disorders, including hypoplastic left heart | syndrome; (ii) total anomalous pulmonary venous return, | not suitable for curative surgical treatment; and (iii) | heart muscle disorders (cardiomyopathies) without adequate | medical or surgical treatments. | (7) End-stage liver disease where (i) transplant is not | a viable option or (ii) transplant rejection or failure has | occurred. | (8) End-stage kidney failure where (i) transplant is | not a viable option or (ii) transplant rejection or failure | has occurred. |
| (9) Metabolic or biochemical disorders, including, but | not limited to, mitochondrial disease, leukodystrophies, | Tay-Sachs disease, or Lesch-Nyhan syndrome where (i) no | suitable therapies exist or (ii) available treatments, | including stem cell ("bone marrow") transplant, have | failed. | (10) Congenital or acquired diseases of the | gastrointestinal system, such as "short bowel syndrome", | where (i) transplant is not a viable option or (ii) | transplant rejection or failure has occurred. | (11) Congenital skin disorders, including but not | limited to epidermolysis bullosa, where no suitable | treatment exists.
| The definition of a life-limiting medical condition shall | not include a definitive time period due to the difficulty and | challenges of prognosticating life expectancy in children. | Section 30. Authorized providers. Providers authorized to | deliver services under the pilot waiver program shall include | licensed hospice agencies or home health agencies licensed to | provide hospice care and will be subject to further criteria | developed by the Department for provider participation. At a | minimum, the participating provider must house a pediatric | interdisciplinary team that includes a pediatric medical | director, a nurse, and a licensed social worker. All members of | the pediatric interdisciplinary team must submit to the |
| Department proof of pediatric End-of-Life Nursing Education | Curriculum (Pediatric ELNEC Training) or an equivalent. | Section 35. Interdisciplinary team; services. Subject to | federal approval for matching funds, the reimbursable services | offered under the pilot program shall be provided by an | interdisciplinary team, operating under the direction of a | pediatric medical director, and shall include, but not be | limited to, the following: | (1) Pediatric nursing for pain and symptom management. | (2) Expressive therapies (music and art therapies) for | age-appropriate counseling. | (3) Client and family counseling (provided by a | licensed social worker or non-denominational chaplain or | spiritual counselor). | (4) Respite care. | (5) Bereavement services. | (6) Case management. | Section 40. Administration. | (a) The Department shall oversee the administration of the | pilot program. The Department, in consultation with interested | stakeholders, shall determine the appropriate process for | review of referrals and enrollment of qualifying participants. | (b) The Department shall appoint an individual or entity to | serve as case manager or an alternative position to assess |
| level-of-care and target-population criteria for the pilot | program. The Department shall ensure that the individual | receives pediatric End-of-Life Nursing Education Curriculum | (Pediatric ELNEC Training) or an equivalent to become | familiarized with the unique needs and difficulties facing this | population. The process for review of referrals and enrollment | of qualifying participants shall not include unnecessary | delays and shall reflect the fact that treatment of pain and | other distressing symptoms represents an urgent need for | children with life-limiting medical conditions. The process | shall also acknowledge that children with life-limiting | medical conditions and their families require holistic and | seamless care.
| Section 45. Period of pilot program. | (a) The program implemented under this Act shall be | considered a pilot program for 3 years following the date of | program implementation or, if the pilot program is created | utilizing a waiver authority, until the waiver that includes | the services provided under the program undergoes the federally | mandated renewal process. | (b) During the period of time that the waiver program is | considered a pilot program, pediatric palliative care shall be | included in the issues reviewed by the Hospice and Palliative | Care Advisory Board. The Board shall make recommendations | regarding changes or improvements to the program, including but |
| not limited to advisement on potential expansion of the | potentially life-limiting medical conditions as defined in | subsection (b) of Section 25. | (c) At the end of the 3-year pilot program, the Department | shall prepare a report for the General Assembly concerning the | program's outcomes effectiveness and shall also make | recommendations for program improvement, including, but not | limited to, the appropriateness of the potentially | life-limiting medical conditions as defined in subsection (b) | of Section 25. | Section 50. Effect on medical assistance program. | (a) Nothing in this Act shall be construed so as to result | in the elimination or reduction of any benefits or services | covered under the medical assistance program under Article V of | the Illinois Public Aid Code. | (b) This Act does not affect an individual's eligibility to | receive, concurrently with the benefits provided for in this | Act, any services, including home health services, for which | the individual would have been eligible in the absence of this | Act.
| Section 90. The Hospice Program Licensing Act is amended by | changing Section 15 as follows: | (210 ILCS 60/15) |
| Sec. 15. Hospice and Palliative Care Advisory Board. | (a) The Director shall appoint a Hospice and Palliative | Care Advisory Board ("the Board") to consult with the | Department as provided in this Section. The membership of the | Board shall be as follows: | (1) The Director, ex officio, who shall be a nonvoting | member and shall serve as chairman of the Board. | (2) One representative of each of the following State | agencies, each of whom shall be a nonvoting member: the | Department of
Healthcare and Family Services, the | Department of Human Services, and the Department on Aging. | (3) One member who is a physician licensed to
practice | medicine in all its branches, selected from the | recommendations of a statewide professional society | representing physicians licensed to practice medicine in | all its branches in all specialties. | (4) One member who is a registered nurse,
selected from | the recommendations of professional nursing associations. | (5) Four members selected from the
recommendations of | organizations whose primary membership consists of hospice | programs. | (6) Two members who represent the general
public and | who have no responsibility for management or formation of | policy of a hospice program and no financial interest in a | hospice program. | (7) One member selected from the
recommendations of |
| consumer organizations that engage in advocacy or legal | representation on behalf of hospice patients and their | immediate families. | (b) Of the initial appointees, 4 shall serve for terms of 2 | years, 4 shall serve for terms of 3 years, and 5 shall serve | for terms of 4 years, as determined by lot at the first meeting | of the Board. Each successor member shall be appointed for a | term of 4 years. A member appointed to fill a vacancy before | the expiration of the term for which his or her predecessor was | appointed shall be appointed to serve for the remainder of that | term. | (c) The Board shall meet as frequently as the chairman | deems necessary, but not less than 4 times each year. Upon the | request of 4 or more Board members, the chairman shall call a | meeting of the Board. A Board member may designate a | replacement to serve at a Board meeting in place of the member | by submitting a letter stating that designation to the chairman | before or at the Board meeting. The replacement member must | represent the same general interests as the member being | replaced, as described in paragraphs (1) through (7) of | subsection (a). | (d) Board members are entitled to reimbursement for their | actual expenses incurred in performing their duties. | (e) The Board shall advise the Department on all aspects of | the Department's responsibilities under this Act, including | the format and content of any rules adopted by the Department |
| on or after the effective date of this amendatory Act of the | 95th General Assembly. Any such rule or amendment to a rule | proposed on or after the effective date of this amendatory Act | of the 95th General Assembly, except an emergency rule adopted | pursuant to Section 5-45 of the Illinois Administrative | Procedure Act, that is adopted without obtaining the advice of | the Board is null and void. If the Department fails to follow | the advice of the Board with respect to a proposed rule or | amendment to a rule, the Department shall, before adopting the | rule or amendment to a rule, transmit a written explanation of | the reason for its action to the Board. During its review of | rules, the Board shall analyze the economic and regulatory | impact of those rules. If the Board, having been asked for its | advice with respect to a proposed rule or amendment to a rule, | fails to advise the Department within 90 days, the proposed | rule or amendment shall be considered to have been acted upon | by the Board.
| (f) The Board shall also review pediatric palliative care | issues as provided in the Pediatric Palliative Care Act. | (Source: P.A. 95-133, eff. 1-1-08.)
| Section 99. Effective date. This Act takes effect upon | becoming law.
|
Effective Date: 7/16/2010
|